Brain Biomarkers | Mild-Mod COVID Treatments
The JournalFeed podcast for the week of July 21-25, 2025.
These are summaries from just 2 of the 5 articles we cover every week! For access to more, please visit JournalFeed.org for details about becoming a member.
Monday Spoon Feed:
Novel blood-based biomarkers, specifically GFAP, UCH-L1, S100B, and NfL, may be well suited for early classification and triage of patients with acute and subacute minor traumatic brain injury.
Tuesday Spoon Feed:
To reduce hospitalizations of patients with mild to moderate COVID, treat with nirmatrelvir-ritonavir (Paxlovid) or remdesivir. To shorten the duration of COVID symptoms, azithroycin, favipiravir, molnupiravir, umifenovir, or corticosteroids may help, but they are not standard of care.
Fler avsnitt av JournalFeed
Visa alla avsnitt av JournalFeedJournalFeed med Nick Zelt finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.